| Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression |
105 |
| Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC |
33 |
| Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) |
32 |
| The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis |
28 |
| Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis |
26 |
| Immunotherapy for head and neck cancer: Recent advances and future directions |
23 |
| Survival outcomes after treatment of cancer of the oral cavity (1985-2015) |
23 |
| The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis |
21 |
| Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database |
20 |
| Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab |
19 |
| Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma |
19 |
| Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma |
18 |
| Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma |
17 |
| Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV plus oropharyngeal carcinoma patients: The Quarterback trial |
17 |
| Smoking impact on HPV driven head and neck cancer's oncological outcomes? |
16 |
| Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review |
16 |
| Prognostic significance of CD68(+) and CD163(+) tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis |
16 |
| Three-dimensional printing of patient-specific surgical plates in head and neck reconstruction: A prospective pilot study |
15 |
| Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options |
14 |
| Accuracy of computer-assisted surgery in mandibular reconstruction: A systematic review |
14 |
| Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer |
14 |
| Double positivity for HPV-DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients |
14 |
| The microbiome and oral cancer: More questions than answers |
14 |
| Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3 beta signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer |
13 |
| Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis |
13 |
| Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer |
13 |
| Oral tongue carcinoma among young patients: An analysis of risk factors and survival |
13 |
| Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review |
13 |
| Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis |
12 |
| Nanomedicine, an emerging therapeutic strategy for oral cancer therapy |
12 |
| Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma |
12 |
| Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas |
12 |
| Elective neck dissection in oral squamous cell carcinoma: Past, present and future |
12 |
| Hypopharyngeal cancer: A state of the art review |
12 |
| Salvage laryngectomy following organ-preservation therapy - An evidence-based review |
12 |
| Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer |
12 |
| Frequent HPV-independent p16/INK4A overexpression in head and neck cancer |
12 |
| Early onset oral tongue cancer in the United States: A literature review |
11 |
| Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity |
11 |
| Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer |
11 |
| Intraoral ultrasonography to measure tumor thickness of oral cancer: A systematic review and meta-analysis |
11 |
| Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer |
11 |
| Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis |
11 |
| Immune profiles in primary squamous cell carcinoma of the head and neck |
10 |
| Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data |
10 |
| Influence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: A pilot study |
10 |
| The risk of carotid stenosis in head and neck cancer patients after radiation therapy |
10 |
| Multi-modality 3D mandibular resection planning in head and neck cancer using CT and MRI data fusion: A clinical series |
10 |
| Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy |
10 |
| Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review |
10 |
